In ccRCC, high densities of C1q-producing TAM revealed an immunosuppressed microenvironment, characterized by high expression of immune checkpoints (i.e., PD-1, Lag-3, PD-L1, and PD-L2), and associated with poor clinical outcomes. The gene discussed is PDCD1LG2; the disease is nonpapillary renal cell carcinoma.